Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer

被引:0
|
作者
Masayuki Sho
Takahiro Akahori
Toshihiro Tanaka
Shoichi Kinoshita
Minako Nagai
Satoshi Nishiwada
Tetsuro Tamamoto
Hideyuki Nishiofuku
Chiho Ohbayashi
Masatoshi Hasegawa
Kimihiko Kichikawa
Yoshiyuki Nakajima
机构
[1] Nara Medical University,Department of Surgery
[2] Nara Medical University,Department of Radiology
[3] Nara Medical University,Department of Radiation Oncology
[4] Nara Medical University,Department of Diagnostic Pathology
来源
关键词
Pancreatic cancer; Prognosis; Preoperative therapy; Neoadjuvant chemoradiotherapy; Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:477 / 485
页数:8
相关论文
共 50 条
  • [1] Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
    Sho, Masayuki
    Akahori, Takahiro
    Tanaka, Toshihiro
    Kinoshita, Shoichi
    Nagai, Minako
    Nishiwada, Satoshi
    Tamamoto, Tetsuro
    Nishiofuku, Hideyuki
    Ohbayashi, Chiho
    Hasegawa, Masatoshi
    Kichikawa, Kimihiko
    Nakajima, Yoshiyuki
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (04) : 477 - 485
  • [2] Neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 392 - 392
  • [3] The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer
    Kim, H. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A138 - A138
  • [4] Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?
    Mroczkowski, Pawel
    Zajdel, Radoslaw
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3347 - 3348
  • [5] Neoadjuvant Chemoradiotherapy is effective in Patients with Pancreatic Cancer
    Di Lellis, Maddalena Angela
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (08): : 1177 - 1177
  • [6] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    [J]. UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [7] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [8] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    [J]. Updates in Surgery, 2016, 68 : 235 - 239
  • [9] The Role of Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer
    Kim, Yoon Jae
    Choi, Jin-Young
    Chung, Yong Eun
    Kim, Hee Man
    Park, Semi
    Kim, Hong Jeoung
    Hong, Sung Pil
    Seong, Jinsil
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Bang, Seungmin
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [10] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +